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The absence of pathologic changes in newborn cystic fibrosis (CF) lung suggests that the fetal CF lung
is inflated with a normal volume of liquid and that CI- is secreted through paths other than the cystic
fibrosis transmembrane conductance regulator (CFTR)-associated CI- channel. We studied liquid con-
tent of distal lung and transepithelial electrical potential difference (PD) of cultured cystic tracheal explants
from 16to 19day gestation fetal mice of CFTR (+/- ) (heterozygous) females that were mated with CFTR
(-/-) "knockout" males. Distal lung water content was not affected by fetal genotype. Basal PDs were
not different (CFTR (+/-),8.6 mY, and CFTR (-/-),9.1 mY), and PDs of both groups were inhibited
by intraluminal injection of amiloride (10-4 M) (-25%) and after addition of bumetanide (10-4 M) to
the bath (-40%). Terbutaline (3 X 10-5 M) induced a similar increase in PD (about 65%) in both
groups. Intraluminal injection of ionomycin (2 x 10-5 and 5 X 10-6 M) raised PD in both groups
(CFTR (+/-) by 32 and 27% and CFTR (-/-) by 41 and 11%). All of the increase in PD induced by
terbutaline and ionomycin was inhibited by bumetanide. The PO response to terbutaline was not attenu-
ated by pretreatment with ionomycin or the Ca2+ chelator BAPTA (10-4 M). Ionomycin or ATP, but not
terbutaline, increased intracellular Ca2 + concentration of isolated cultured tracheal epithelial cells. The
response of CF epithelium to l3-adrenergic agonist suggests that cyclic AMP-activated CI- pathways
other than those linked to CFTR regulate liquid secretion in fetal mouse airways.
Our understanding of the mechanisms that control CI- se-
cretion in the fetal lung (1) is incomplete. Cystic fibrosis
transmembrane conductance regulator (CFTR) is thought to
function as a cyclic AMP (cAMP)-regulated CI- channel
(2). The presence of abundant CFTR in fetal airways (3) sug-
gests that this protein may have an important role in liquid
secretion, but the absence of functional CFTR protein in CF
fetuses does not appear to impede secretion of lung liquid.
An alternative, Ca2+-activated CI--secretory pathway has
been shown in the respiratory epithelia of both fetal and post-
natal human lung (4, 5). This path can be stimulated by
inflammatory mediators and purinergic agents (4-6) and is
the focus of therapeutic strategies to overcome defective
CI- secretion in CF patients (7).
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Agents that raise cell cAMP concentration induce CI-
secretion by airway epithelia of adult mammalian lung (8-10)
and Na+ absorption by alveolar or whole lung preparations
(11, 12). The action of cAMP in the fetal lung is more com-
plex. cAMP has a stimulatory effect on liquid and CI-
secretion by both proximal and distal regions of excised or
cultured immature fetal lung (4, 8-10, 13-16). However, late
in gestation, secretion of liquid by the lung in vivo is in-
hibited or switched to absorption by infusion of epinephrine
into fetal sheep (17), an effect that is mediated by Na' ab-
sorption in the distal lung. Initiation of absorption helps to
clear liquid from the lumen at the time of birth and prepares
the fetal lung for air breathing. There is no evidence that this
adaptive response is abnormal in neonates with cystic fibro-
sis (CF).
Development of a transgenic mouse model of CF by gene
deletion (18) provides an opportunity to study the reliance
of fetal liquid secretion on paths of ion permeation linked to
CFTR. In this study, we compared the basal secretion oflung
liquid by distal lung by measuring the water content of lungs
excised from CF (CFTR -/-) and heterozygote (CFTR
+/-) late-gestation fetal mice (term = 19 days). We also
measured the transepithelial electrical potential difference
(PD) across cultured cystic explants derived from fetal tra-
chea. We evaluated the relative importance of secretory
paths that are activated by second messengers from voltage
changes induced by agents that raise intracellular cAMP or
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Ca2+. We also measured intracellular Ca2+ concentration
([Ca2+]) to assess possible cross-activation of the Ca2+-
sensitive pathwayby terbutaline, a l3-adrenergicagonist and
a traditional activator of the cAMP-mediated path.
Materials and Methods
Fetal mice were produced by mating males homozygous for
CFTR gene deletion, CFTR (-/-), with females who were
heterozygous carriers of the defect (CFTR (+ /- )). In addi-
tion, we studied fetal lungs from two litters that were the
product of CFTR (+/-) mothers mated with CFTR (+/ +)
fathers. Fetuses were removed after the dams were killed by
CO2 inhalation.
Wet:Dry Weight Measurements
Fetal lungs with trachea from three litters were excised,
and the trachea was clamped. The lungs were blotted with
premoistened filter paper, and the lobes were separated from
the main bronchi and dropped into a tared flask. The flasks
with tissue were weighed wet and dry (> 14 h at 80°C) as
described previously (19).
Explant Culture
Tracheas were explanted into submersion culture as de-
scribed for trachea and distal lung of fetal rat (13). Briefly,
tracheas were excised and placed in an isosmotic collagen-
salt solution that gelled after incubation at 37°C. Explants
submerged in the gel were bathed in F12 supplemented with
10% fetal bovine serum, 10 mM HEPES (pH 7.4), and 2 mM
NaHC03 • Explants were cultured at 37°C in a 95% air-5%
CO2 environment for 7 days. Culture medium was changed
every 48 h.
Basal PD and the Effects of Drugs on PD
After 7 days in culture, PD was measured across the walls
of all explants that formed liquid-filled cysts. Cysts were im-
paled with a glass microelectrode filled with 3 M KCl (tip
resistance ranged from 5 to 40 MO) as described previously
(13). The electrode was connected through an Ag-AgCl half
cell to a high impedance voltmeter and referenced to a bridge
(3% agar in bath medium) in the bath through a calomel half
cell. PD was measured continuously through a period of
basal PD measurement and during changes induced by drugs
that were added to the cyst lumina or bath.
Terbutaline sulfate (3 x 10-3 M in saline; Geigy, Ards-
ley, NY) or bumetanide (10-1 M in dimethyl sulfoxide;
Sigma Chemical Co., St. Louis, MO) was added to the bath
to give a final concentration of 3 X 10-5 or 10-4 M, respec-
tively. When drugs that act from the lumen were tested, a
measured volume of vehicle (with or without drug) was
microinjected into the cyst lumen with a glass pipette with
a bevelled tip (diameter = 5 to 15 #-tm [13]). The injected
bolus was equivalent to 1% of average cyst volume. Conse-
quently, stock solutions of amiloride HCl (10-2 M in water;
gift from Merck Sharp and Dohme, West Point, PA) and Ca
ionomycin (5 X 10-4 or 2 x 10-3 M in 10 to 20% ethanol;
Boehringer Mannheim, St. Louis, MO) were expected to be
diluted to 10-4 M and 5 x 10-6 M or 2 x 10-5 M, respec-
tively. Impalement by the injection pipette caused a transient
change in PD (mean = -10%, range = +10% to -45%
change from the stable baseline [defined as < 0.5 mV
change/2 min]). All drug responses are reported as the first
stable values after microinjection or exposure to drug in the
bath. One-hour control experiments with continuous impale-
ment with a recording electrode showed a small decline in
basal PD over this time (Table lA).
Genotype Determination
Genomic DNA was prepared from the tail and one leg of
each fetus by the salting-out method adapted from Miller and
colleagues (20). DNA from each fetus was amplified by two
different polymerase chain reactions (PCR). One set of
primers is specific for wild-type DNA and yields a PCR
product (identified by gel electrophoresis) only when wild-
type DNA is present. The second primer set is specific for
targeted (disrupted) CFTR DNA and yields a PCR product
only when targeted DNA is present. DNA from a heterozy-
gous fetus yields a PCR product from both PCR, whereas
DNA from a homozygous CF fetus yields only the targeted
DNA product. Both PCR amplifications were repeated to
verify CF genotype. Genotype was determined 2 to 3 wk af-
ter removalof the fetus from the dam so that the investigators
were unaware of the origin of the tissue during studies of
function.
Calcium Measurements
Individual fetal tracheal epithelial cells were isolated by in-
cubation of fetal trachea with protease 0.1% in minimal es-
sential medium for 2 h at 37°C and cultured in F12 plus 10%
fetal bovine serum for 18 to 36 h on vitrogen-coated cover-
slips. Cells were loaded with Fura-2/AM, and fluorescence
was induced and measured with a modular fluorimeter sys-
tem (Fluorolog 2, model F2C; Spex Industries, Edison, NJ)
attached to an inverted microscope (Nikon) as described pre-
viously (21).
Statistics
Differences between basal PDs and PDs after exposure to
drugs were compared by the paired t test. When more than
one drug was added during the experiment, we adjusted the
t value for significance (0.05) with the Bonferroni correc-
tion. Differences between lung weights, basal PD, or drug-
induced PD changes for -explants with different genotypes
were compared by the Mann-Whitney U test. Percentage
changes in PD are normalized to the basal PD.
Results
Effect of Genotype on Fetal and Lung Growth
Timed pregnancies of heterozygote (CFTR (+/- )) females
mated with homozygous "knockout" males without CFTR
(CFTR (- /-)) produced 20 litters, with an average litter size
of 8.9 ± 0.6 fetuses. Litter sizes of two pregnancies in which
the father was CFTR (+ /+) were 5 and 8 fetuses. There was
no trend between the proportion of CF (-/-) in a litter
and litter size. Eighty of a total of 177 fetuses from CFTR
(+/-) and CFTR (-/-) mating had a CFTR (-/-) geno-
type (46%).
Fetal weights, dry lung weights, and water weight/dry
lung weight ratios were not different for CFTR (+/-) and
CFTR (-/-) fetuses from three litters measured at 16, 17,
and 18 days of gestation (Figure 1).
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TABLE 1
A. Control data*
a Basal Time Elapsed
a PO (mV) PO (%) (min) n
Time control -0.8 ± 1.1 -11 50 3
Saline injection -0.1 ± 0.2 -2 5 5
B. Effect of drugs*t
a Basal
Drug Added Pretreatment CFTR a PO (mV) PO (%) n
Amiloride (10- 4 M) None +/- -2.1 ±0.2 -25 58
-/- -2.9 ± 0.3 -29 26
+/+ -1.6 ± 0.5 -19 5
Bumetanide (10-4 M) None +/- -2.1 ± 0.4 -35 4
-/- -2.4 ± 0.4 -42 4
BAPTA (10- 4 M) None +/- -6.2 ± 1.1 -33 4
-/- -2.6 ± 1.3 -20 4
Terbutaline (3 X 10-5 M) None +/- 6.1 ± 0.4 67 11
-/- 4.8 ± 0.6 65 12
Amiloride +/- 5.8 ± 0.4 59 14
-/- 5.2 ± 0.7 61 8
+/+ 4.6 ± 0.7 60 6
Amiloride/ionomycin
(5 X 10-6 M) +/- 4.2 ± 0.5 60 21
-/- 3.6 ± 0.9 34 6
Amiloride/ionomycin
(2 x 10-5 M) +/- 1.8 ± 0.6 33 8
-/- 1.7 ± 0.6 29 5
BAPTA +/- 7.1 ± 0.5 63 5
-/- 4.6 ± 1.2 67 3
Ionomycin (5 X 10-6 M) Amiloride +/- 2.2 ± 0.3 27 21
-/- 1.2 ± 0.3 11 6
Ionomycin (2 X 10-5 M) Amiloride +/- 2.4 ± 0.7 32 8
-/- 2.7 ± 0.6 41 5
Ionomycin (5 X 10-6 M) Amiloride/terbutaline +/- 0.5 ± 0.1 6 14
-/- 1.1 ± 0.3 13 8
+/+ 1.2 ± 0.3 15 5
* All values are mean ± SEM.
t a PO values are significantly different from pretreatment values except for changes in PO after ionomycin, following pretreatment with amiloride and ter-
butaline.
Tracheal Explants
In submersion culture, the cut ends of tracheas sealed over
within 48 h in 91% CFTR (+/-) explants and 95% CFTR
(- /-) explants, resulting in the formation of cystic struc-
tures by liquid secretion into the lumen. After 7 days in cul-
ture, the tracheal epithelium of explants from both genotypes
(CFTR (+/-) and CFTR (-/-» was well differentiated,
with a mix of ciliated and nonciliated cells (Figure 2).
Transepithelial PD
After 7 to 9 days in culture, mean basal PDs of CFTR (+/+)
(7.2 ± 0.7, n = 12), CFTR (+/-) (8.6 ± 0.4 mY, n = 87),
and CFTR (- / -) (9.1 ± 0.6 mY, n = 50) explants were not
different.
The relative contributions to total resting PD of Cl
secretion and Na + absorption were evaluated from the re-
sponse to the Na+/CI- cotransport blocker bumetanide in
the bathing solution and amiloride injection into the cyst lu-
men. Bumetanide caused a gradual decline of PD over 60
min to 65% of basal values for CFTR (+/-) and 58% of
basal PD for CFTR (-/-) (Table IB). Resting PD was in-
hibited within 30 s of amiloride injection. By steady state (5
min after injection), the change in PD from basal values
across CFTR (+/-) explants (-25 %) was similar to that of
CFTR (-/-) explants (-29%) injected with amiloride (Ta-
ble IB). Injection of an equivalent volume of saline (7 nl) did
not induce a significant change in PD over the same time (Ta-
ble IA).
Explants were exposed to a selective 132-adrenergic ago-
nist, terbutaline, and to the Ca2+ ionophore ionomycin to
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Figure 1. Gravimetric analysis of CFTR (+/-) (shaded bars) and
CFTR (- /-) (closed bars) fetuses at 16, 17, and 18 days of gesta-
tion. a. Mean lung water/dry weight ± SEM. b. Mean lung dry
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lar increases in PD when explants of both genotypes were
exposed to terbutaline, but these responses were signifi-
cantly smaller than those for explants that were not pre-
treated with ionomycin.
When the order of drug addition was reversed and
ionomycin (5 x 10-6 M) was injected into CFTR (+/-)
Figure 2. Cystic tracheal explant from 19 day gestation CFTR
(-/-) fetus after 7 days in culture. A. Low-power light micrograph
of explant in submersion culture shows cut ends sealed over and tra-
cheal rings well preserved. Bar = 500 JLm. B. Cross-section of
fixed explant, stained with Richardson stain. Bar = 60 ILm. C.
High-power view of cross-section of fixed explant shows a mix of
ciliated and nonciliated epithelial cells, with underlying layers of
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test for cAMP- and Ca2+-mediated changes in PD. Terbuta-
line raised basal PD by 65 to 67% in CFTR (+/-) and
CFTR (- /-) explants (Table IB). Pretreatment with amilo-
ride did not affectstimulation of PD across CFTR (+/- ) and
CFTR (-/-) cysts by terbutaline (Table IB).
Ionomycin was added to the bath or injected into cysts that
had been pretreated with amiloride. Addition of ionomycin
to the bath tended to increase PD slightly, but this change
was not significant. The higher dose of ionomycin (2 X
10-5 M) resulted in frequent pipette plugging, short-lived
formation of precipitate within the cyst, and a significantly
greater increase in the PD of CFTR (- /- ) explants (2.7 mY)
compared with the lower dose (1.2mY)(Table IB). The mag-
nitude of responses to ionomycin for CFTR (+/-) explants
was the same for both doses (Table IB).
After the response to ionomycin had stabilized, terbuta-
line (10-5 M) was added to the basolateral bath. The abso-
lute increase in PD induced by subsequent addition of ter-
butaline was not different for explants pretreated with 5 X
10-6 M ionomycin, but the percentage increase for the
CFTR (- /-) group (34%) tended to be less than that for the
CFTR (+/- )group (60%) because the basal PD of the CFTR
(- /-) group was greater. The fractional contribution of the
terbutaline-stimulated PD to the total change in PD induced
by terbutaline and ionomycin was, however, the same for
both groups (0.73in CFTR (+/-) and 0.70 in CFTR (-/-».
Pretreatment with 2 X 10-5 M ionomycin resulted in simi-
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Figure 3. Time course of transepithelial PD across tracheal explant
from 18 day gestation CFTR (+I-) fetus. Upward arrows show in-
sertion into and withdrawal of the microelectrode from the cyst lu-
men. First downward arrow denotes impalement of the cyst with a
micropipette. Subsequent downward arrows show times of amilo-
ride (10-4 M) microinjection, terbutaline (5 X 10-5 M) addition to
the bath, ionomycin (5 x 10-6 M) microinjection, and bumetanide
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Figure 4. Time course of transepithelial PD across tracheal explant
from 17 day gestation CFTR (-1-) fetus. BAPTA (10-4 M) was
added to the bath. After 40 min, terbutaline (5 x 10-5 M) was
added to the bath. Note the change in time scale after addition of
terbutaline.
Discussion
Our study shows that fetal growth, lung growth, and water
content of distal lungs excised from heterozygote and "knock-
out" CF fetal mice late in gestation were not different. We
also found that, in general, PD responses of tracheal explants
from the three genotypes (CFTR (+1+), CFTR (+/-), and
CFTR (-/- » to drugs that affect Na+ or CI- flux across
respiratory epithelia were not different.
The proportion of CF (-/-) fetuses per litter (0.46) was
close to that predicted from parental genotype (0.5). A trend
towards a lower-than-expected proportion of CF fetuses was
noted at all litter sizes. If confirmed by studies of larger
populations, this finding would be more likely to result from
problems with conception (e.g., a smaller frequency of via-
ble CFTR (-) eggs or sperm), rather than from fetal death.
The similaritybetweenvoltagechangesinducedby{J-adren-
ergic agonists in CFTR (- I-) and CFTR (+/ -) explants
contrasts with the minimal bioelectric response to cAMP in
explants and monolayers cultured from human fetal distal
CF lung (15, 22). Although basal PD and liquid secretion
TIME (sec)
Figure 5. Time course of ftuorometric analysis of intracellular




















explants that had been exposed to amiloride and terbutaline,
the hyperpolarization response was smaller than with ex-
plants pretreated with amiloride alone (Table IB). The
ionomycin response of CFTR (-/-) explants pretreated
with terbutaline was not attenuated (Figure 3). Bumetanide
(10-4 M) was added to the bath when PD stabilized after
addition of ionomycin and terbutaline (usually about 6 min
after addition ofterbutaline). We observed an abrupt inhibi-
tion of stimulated PD (Figure 3) that stabilized within 10 to
20 min (CFTR (+/-), -102 ± 9%, n = 11; CFTR (-/-),
-110 ± 8%, n = 4). Without bumetanide, PD increased
slowly by an additional 23 ± 6% (n = 6) between 6 and 14
min after addition of terbutaline.
Cell Calcium and the Terbutaline Response
Activation of a Ca2+-dependent path by the {J-adrenergic
agonist was tested by pretreating explants with an intracellu-
lar Ca2+ chelator, BAPTA (10-4 M in the bath), for 45 min
before addition of terbutaline (3 x 10-5 M) to the bath
(Figure 4). BAPTA caused a fall in basal PD of 33% in
CFTR (+/-) and 20% in CFTR (-/-). Subsequent ex-
posure to terbutaline induced the same increase in PD in
both groups (Table IB). The magnitude of the change was
similar to that induced by terbutaline alone.
We also measured changes in intracellular [Ca2+] (Fura-2
fluorescence) induced by terbutaline, forskolin, ionomy-
cin, and ATP in ciliated and nonciliated tracheal epithelial
cells (from 6 fetuses: 2 CFTR (-/-), 1 CFTR (+/-), and
3 CFTR (+/+» that were cultured for 24 to 48 h on
vitrogen-coated coverslips. Terbutaline (5 X 10-5 M) or
forskolin (10-5 M) induced no change in baseline intracel-
lular [Ca2+] . Ionomycin (5 X 10-6 M) or ATP (10-4 M)
caused a transient 5- to 14-fold increase in [CaH ] followed
by a plateau that was about twice the basal [Ca2 +] (Figure
5). We detected no clear difference in the pattern of response
between ciliated and nonciliated cells or between different
genotypes.
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were reported to be similar in normal and CF human fetal
explants, stimulation of PD by adrenergic agonists was de-
tected only in non-CF explants. The differences in response
to cAMP in the midtrimester CF human fetal distal lung
compared with response in the late-gestation fetal mouse
trachea may relate to gestational and regional differences in
the tissues used in these studies. This possibility draws some
support from studies of CFTR expression in normal human
fetal lung which show that CFTR expression diminishes in
tracheal epithelium in late gestation while persisting at higher
levels in small airways (3). Our attempts to study the bioelec-
tric properties of cultured explants from the distal mouse
lung were not successful because of poor cyst formation. Al-
ternatively, the minimal bioelectric responses to cAMP in
the human CF fetal studies may indicate a greater impor-
tance of CFTR-linked CI- path in human fetal lung than in
mouse fetal lung.
The hyperpolarization we observed after terbutaline
and ionomycin exposure is likely to reflect stimulation of
CI- secretion since preparations had been pretreated with
amiloride, and CI- and Na' are thought to be the principal
ions transported across the fetal pulmonary epithelium. The
rapid inhibition of this hyperpolarization by bumetanide
is further evidence that CI- secretion was stimulated by
ionomycin and terbutaline. We sought to explain the appar-
ent CI- -secretory response to {3-adrenergic agonist, the
hallmark defect of postnatal CF airways epithelia, by the tra-
chea of CF fetal mouse. First, terbutaline could raise intra-
cellular [Ca2+] and activate CI- channels not associated
with CFTR. Interaction of cAMP with Ca2+-activated chan-
nels in CF tracheas seemed unlikely because the absolute in-
crease in PD induced by doses of ionomycin that are close
to the limit of solubility was smaller than that induced by a
maximal dose of terbutaline. More direct evidence against
mediation of the terbutaline response by CaH is provided
by the absence of an inhibitory effect of BAPTA on the ter-
butaline response and by the absence of any measurable
change in intracellular [CaH ] after terbutaline or forskolin
in isolated tracheal epithelial cells.
There was, however, evidence for interaction between the
two drugs at some point in the stimulation-effect sequence
because pretreatment with one agonist sometimes blunted
the subsequent response to the other. The trend was, how-
ever, not restricted to CFTR (-/-) explants (Table lB).
The best-described example of cAMP activation of Ca2+-
dependent channels is the excised trachea of the adult mouse
described by Grubb and co-workers (23). This preparation
is characterized by a maximal cAMP stimulation of short-
circuit current that is substantially smaller than that induced
by ionomycin. In addition, the response to cAMP is blocked
by BAPTA and paralleled by a clearcut increase in [Ca2+]
of tracheal epithelial cells. By contrast, fetal tracheal ex-
plants respond more vigorously to {3-adrenergic agonist than
to ionomycin. Although they are depolarized by BAPTA,
fetal preparations share neither BAPTA inhibition of the
cAMP response nor changes in cell [Ca2+] with the tracheal
epithelium of the adult. Fetal and postnatal [CaH ] were
measured in similar preparations (i.e., recently isolated sin-
gle cells) and gave different results, but the possibility exists
that cAMP may induce a rise in [Ca2+] in confluent fetal
epithelial barriers. In addition, pretreatment of postnatal
mouse trachea with ionomycin eliminated the forskolin re-
sponse, whereas similar pretreatment of fetal mouse tracheal
explants with ionomycin had no effect on the subsequent de-
polorization response to terbutaline. Consequently, the pat-
tern of interaction between terbutaline and ionomycin we de-
scribed above is more likely to result from voltage change
limited by the establishment of a dominant permeability
(e.g., PC1- of the apical membrane and/or PK+ of the baso-
lateral membrane) than by mediation of the effect through a
common CI- channel. Accordingly, we conclude that there
is minimal crossover of the cAMP message to Ca2+-activated
channels in fetal tracheal explants from both genotypes.
The CI- -secretory responses of tracheal preparations
from postnatal mouse (5, 23) suggest that the CI- -secretory
response of airway epithelium to cAMP diminishes after
birth while responsiveness to intracellular [Ca"] increases.
A similar reciprocal switch from dominant cAMP- to domi-
nant [Ca'<l-activated cell volume regulation and CI- efflux
has been described for distal fetal rat lung epithelial cells in
the last few days of gestation (24). In that-study, cAMP effects
were inhibited by incubation with antisense oligodeoxy-
nucleotides to the human CFTR gene. These observations
suggest that a decline in CFTR mRNA may account for the
emergence of a dominant Ca2+-activated CI- conductance
in specific regions of the postnatal lung.
The brisk bioelectric responses of fetal CF mouse tra-
cheal explants to terbutaline contrasted with the relatively
small (compared with ionomycin) responses to forskolin in
freshly excised trachea from both normal and adult CF mice
(23). When postnatal tracheal epithelial cells were cultured
on collagen membranes, however, forskolin induced a small
increase in short-circuit current across preparations from
normal but not CF mice (5).
The lack of any detectable differences in distal lung water
content or dry lung weightsbetween CFTR (+/-) and CFTR
(- /-) explants suggests that fetal lung liquid production
and lung growth is not affected in the CF fetus, and is concor-
dant with the observation that lungs from CF human fetuses
are normal at birth. The response of the CF fetal tracheal
explants to terbutaline raises the possibility that cAMP-
activated CI- channels.tether than those associated with
CFTR, exist in the developing fetal mouse trachea. Non-
CFTR cAMP-sensitive CI- channels have not, as yet, been
described. .
The fetal CF lung may be protected from the conse-
quences of abnormal CI- transport for other reasons. Our
study shows that a CaH -activated CI- -secretory pathway,
similar to those described for human fetal distal lung (4) and
a variety of postnatal epithelia, is present in tracheal epithe-
lium from both CFTR (+/-) and CFTR (-/-) fetuses, and
this path may protect fetuses with abnormal CFTR. The ob-
servation that baseline liquid secretion and basal PD of cul-
tured distal lung explants from human CF fetuses was not
compromised (15) suggests that CFTR-linked CI- transport
may not be required for basal liquid secretion in the fetal
lung. This possibility is supported by in vivo studies of fetal
sheep lung which show that epinephrine decreases lung liq-
uid secretion (17) during the latter part of gestation. Conse-
quently, l3-adrenergicagonist stimulation of secretion by air-
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ways of the mature fetus is overridden by events in the dis-
tal lung where liquid is absorbed in response to the same
t3-adrenergic stimulus. Because amiloride inhibition of the
PD was small and not different for tracheas explanted from
fetuses of both genotypes, we conclude that fetal CF airway
epithelium is not characterized by hyperabsorption of Na'
that defines CF large airway epithelia in postnatal life (25).
Basal liquid secretion by the fetal pulmonary epithelium may
be adequate for lung development in the CF fetus but in-
sufficient to hydrate the CF airway when hyperabsorptive
forces are recruited in postnatal life.
In addition to ion transport mechanisms, mechanical fac-
tors might protect the CF fetal lung from the effectsof liquid
hyposecretion. Normal lung growth is dependent on the
maintenance of the developing lungs in a state of balanced
expansion, so that underinflation or overexpansion of the
lung in utero leads to lung hypoplasia or hypertrophy, re-
spectively (26). But, even if the liquid secretion rate in the
fetal CF lung is diminished, autoregulation of fetal lung vol-
ume and hydrostatic pressure by control of liquid efflux (27,
28) may allow the CF fetal lung to expand sufficiently for
normal development.
Our study points to the possible existence of cAMP-
activated CI- channels that are not linked to CFTR and
provides a rationale for the observation that the lungs of new-
born infants with CF develop normally. Further study of
these fetal lung secretory mechanisms may lead to better un-
derstanding of the physiologic role of CFTR in the fetal
lung and novel approaches to the treatment of CF in the post-
natal lung.
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